Cleared Traditional

K190675 - Dimension EXL High-Sensitivity Troponin...

K190675 is the FDA 510(k) clearance for Dimension EXL High-Sensitivity Troponin... by Siemens Healthcare Diagnostics, Inc.. It is a Class 2 Chemistry device (product code MMI) cleared through the Traditional 510(k) pathway after a 63-day FDA review.

K190675 · Siemens Healthcare Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2019
Decision
63d
Days
Class 2
Risk

K190675 is an FDA 510(k) clearance for the Dimension EXL High-Sensitivity Troponin I (TNIH) Assay. Classified as Immunoassay Method, Troponin Subunit (product code MMI), Class II - Special Controls.

Submitted by Siemens Healthcare Diagnostics, Inc. (Newark, US). The FDA issued a Cleared decision on May 17, 2019 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Siemens Healthcare Diagnostics, Inc. devices

Submission Details

510(k) Number K190675 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 15, 2019
Decision Date May 17, 2019
Days to Decision 63 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 88d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MMI Immunoassay Method, Troponin Subunit
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - MMI Immunoassay Method, Troponin Subunit

All 68
Devices cleared under the same product code (MMI) and FDA review panel - the closest regulatory comparables to K190675.
Alinity i STAT High Sensitivity Troponin-I
K202525 · Abbott Laboratories Diagnostics Division · May 2022
Elecsys Troponin T Gen 5
K201441 · Roche Diagnostics · Sep 2021
ARCHITECT STAT High Sensitivity Troponin-I
K191595 · Abbott Laboratories Diagnostics Division · Sep 2019
Dimension Vista High-Sensitivity Troponin I (TNIH) Assay
K182225 · Siemens Healthcare Diagnostics, Inc. · Mar 2019
Atellica IM High-Sensitivity Troponin I (TNIH)
K171566 · Siemens Healthcare Diagnostics, Inc. · Jul 2018
ADVIA Centaur High-Sensitivity Troponin I (TNIH)
K171274 · Siemens Healthcare Diagnostics, Inc. · Jul 2018